Picture of Hikma Pharmaceuticals logo

HIK Hikma Pharmaceuticals Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Hikma Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line491558544233281
Depreciation
Amortisation
Non-Cash Items3484108112117
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-152-269-159-187-49
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities472464638530608
Capital Expenditures-186-224-229-225-204
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items35-59-9-382-129
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-151-283-238-607-333
Financing Cash Flow Items-48-34-53-77-97
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-155-298-287-58-337
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash166-119103-156-65